Vier Arme des Operationsroboters um Daniel Eberli

Story

Into the Future with Robotics

The Department of Urology frequently performs robot-assisted surgeries. Daniel Eberli helped pioneer the introduction of this innovative surgical technique at the USZ, and as clinic director, he intends to continue developing the team’s robotic expertise.

Like a giant spider, the surgical robot’s four arms wrap themselves around Daniel Eberli. But just for the photo. During surgeries, the clinic director stands at the control terminal and directs the robotic arms, which are equipped with delicate precision instruments. “With robot-assisted surgery, we can operate with greater precision than my hand ever could.” The scissors, for example, have blades that aren’t even as big as the smallest Victorinox pocket knife. Ten years of clinical experience, 450 robotic procedures, and certifications in specialized robotic techniques set the new head of the Department of Urology apart.
His enthusiasm for robot-assisted surgery is no coincidence. “In urology, we recognized the benefits for our patients early on. They lose virtually no blood during the procedure, we can work with great precision, and recovery time is significantly reduced.” Another advantage is that these new technological advancements allow us to preserve organs and tissues. It is no coincidence that the Department of Urology at the USZ is one of the most innovative institutions in Switzerland, with strong capacity for development, and attracts both trainees and patients from all over the world.

Knowledge Transfer Within the Team

Meanwhile, technical expertise is advancing rapidly. “I expect that in each of our departments, at least two team members will be world-class.” To that end, Daniel Eberli relies on collaboration and knowledge sharing. During assignments at hospitals abroad, surgeons are expected to acquire new technological knowledge, bring the techniques they have learned back to the USZ, and continue to develop them as part of a team.

With robot-assisted surgery, Daniel Eberli is also clearly meeting the needs of his primary clientele. 75 percent of his patients are male and in the second half of their lives. “Many men are tech-savvy and expect state-of-the-art equipment during procedures.” 6,000 new cases of prostate cancer are recorded in Switzerland each year. 1,500 people, mostly elderly men, die from it. “This means that a great many patients can be treated successfully,” said Daniel Eberli.

Stem Cells for the Treatment of Urinary Incontinence

Women also seek care at the Department of Urology, even though they are clearly in the minority. Her symptoms mainly involve kidney disease or urinary incontinence. “Incontinence is a source of shame and is still considered a taboo subject,” says clinic director Daniel Eberli. In Switzerland alone, it is estimated that more than 400,000 women and men are affected. This may be due to a weakening of the pelvic floor or the bladder sphincter. The Continence and Pelvic Floor Center, a joint program offered by various clinics at the USZ, provides treatment options for these conditions.

Through stem cell research, however, the clinic’s in-house research laboratory is exploring a new therapeutic approach to urinary incontinence. This is because stem cells can take over the muscle function of the tissue into which they are implanted. “When stem cells are implanted into the bladder sphincter, they develop into sphincter cells,” explains Daniel Eberli. The USZ is a world leader in this field of research. The first clinical trial, involving 60 female participants, is currently underway. “We see great potential in this for a lasting improvement in our patients’ quality of life.”

Hand in Hand: Technology and Research

The fact that urology was on the verge of major advances around the turn of the millennium played a decisive role in Daniel Eberli’s choice of medical specialty. Tullio Sulser, his predecessor as clinic director, became his mentor and was particularly supportive of Eberli’s second area of expertise: stem cell research. Daniel Eberli gained this knowledge during a year of research at Harvard Medical School in Boston and a three-year PhD program in molecular medicine at Wake University in North Carolina. After returning in 2008, he established the stem cell research laboratory at the USZ.

For Daniel Eberli, the transition to the role of hospital director represents an exciting change of perspective. “Tullio Sulser always saw the big picture and kept pushing me forward whenever I was in danger of getting bogged down in research or technical details. Now it’s my turn to motivate my team and look toward the future.”

Beyond Cutting-Edge Medicine: Development Cooperation

In addition to technological advances in cutting-edge medicine, Daniel Eberli places great importance on development cooperation. Last year, together with his team, he established the infrastructure for modern treatment options for benign prostate enlargement at the University Hospital in Kara, Togo; trained the staff; and successfully performed the first procedures. “To save lives there, you need compassion and skill, not robots,” explains Daniel Eberli.

Contact us

Daniel Eberli, Prof. Dr. Dr. med.

Director of Department, Department of Urology

Tel. +41 44 255 54 01
Specialties: Prostate cancer: 3D prostate biopsies (MRI fusion, stereotactic), DaVinci robotics and laparoscopy, HIFU (High Intensity Focused Ultrasound), Robotic surgery (kidney and bladder), Treatment of benign prostate enlargement

Responsible Department